1-4 of 4
Jianpei Fang
Close
Sort by
Journal Articles

Safety and Efficacy of RM-001 (Autologous HBG1/2 Promoter-modified CD34+ Hematopoietic Stem and Progenitor Cells) in Patients with Transfusion-Dependent β-Thalassemia

Rongrong Liu, Li Wang, Hui Xu, Xiaolin Yin, Junbin Liang, Wenqiang Xie, Gaohui Yang, Yaoyun Li, Yali Zhou, Lei Shi, Bin Xiao, Lingling Shi, Zeyan Shi, Xuemei Zhou, Xiangmin Xu, Jianpei Fang, Yongrong Lai, Junjiu Huang, Xinhua Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4994.
https://doi.org/10.1182/blood-2023-181453
Published: 2023
Journal Articles

Preliminary Result of the Safety and Efficacy of Autologous HBG1/2 Promoter-Modified CD34+ Hematopoietic Stem and Progenitor Cells (RM-001) in Transfusion-Dependent Βeta-Thalassemia

Rongrong Liu, Hui Xu, Junbin Liang, Wenqiang Xie, Gaohui Yang, Lei Shi, Lingling Shi, Jianpei Fang, Chunfu Li, Zeyan Shi, Xuemei Zhou, Junjiu Huang, Yongrong Lai
Journal: Blood
Blood (2022) 140 (Supplement 1): 4915–4916.
https://doi.org/10.1182/blood-2022-169151
Published: 2022
Journal Articles

The Clinical Research of Umbilical Cord Blood Transplantation for Children with Leukemia or Whom with Beta-Thalassemia.

Jianpei Fang, MD, Shaoling Huang, MD, Dunhua Zhou, MD
Journal: Blood
Blood (2005) 106 (11): 5435.
https://doi.org/10.1182/blood.V106.11.5435.5435
Published: 2005
Journal Articles

Using the NOD/SCID Mice Model of Human Erythroleukemia for Evaluating the Cytotoxicity Activity of CB-CIK/NK Cells Stimulated by K562-DCs Fusion Vaccines.

Yang Li, Shaoliang Huang, Jianpei Fang, Xuchao Zhang, Jing Wei, Wenge Huang, Yanfeng Wu
Journal: Blood
Blood (2005) 106 (11): 5240.
https://doi.org/10.1182/blood.V106.11.5240.5240
Published: 2005